Stay updated on Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.

Latest updates to the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdministrative updates were added on 2025-10-27 and 2025-10-29, with deletions on 2025-10-13 and 2025-10-20. There are no changes to the study design, eligibility criteria, primary outcomes, or reported results.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedReplace and update hospital names (Vall d Hebron / La Paz) with updated forms, and refresh date entries to more recent dates. If no other context, core content and proper nouns were updated.SummaryDifference0.3%

- Check38 days agoChange DetectedCore content updated with an operational status notice and a new version (v3.2.0); previous version (v3.1.0) removed.SummaryDifference2%

- Check45 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0, signaling a new release/version without altering core content.SummaryDifference0.1%

- Check52 days agoChange DetectedUpdated study details: location expanded to Ankara, Türkiye with a hospital name and country specified, updated count to 109 locations, and new last update timing; older data (108 locations and earlier update date) removed.SummaryDifference0.6%

- Check60 days agoChange DetectedUpdated hospital names to West China Hospital of Sichuan University and Motol University Hospital, and bumped to revision v3.0.2; added recent dates (2025-09-12, 2025-11-28, 2025-09-02, 2025-09) while removing older dates and the previous revision (v3.0.1) plus the Back to Top link.SummaryDifference0.7%

Stay in the know with updates to Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.